No abstract available
MeSH terms
-
Ado-Trastuzumab Emtansine
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Azepines / therapeutic use
-
Biphenyl Compounds / therapeutic use
-
Canagliflozin
-
Cholesterol Ester Transfer Proteins / antagonists & inhibitors
-
Dimethyl Fumarate
-
Drug Approval*
-
Forecasting
-
Fumarates / therapeutic use
-
Glucosides / therapeutic use
-
Humans
-
Lactones / therapeutic use
-
Maytansine / analogs & derivatives
-
Maytansine / therapeutic use
-
Pyridines / therapeutic use
-
Sofosbuvir
-
Sugammadex
-
Thiophenes / therapeutic use
-
Trastuzumab
-
Triazoles / therapeutic use
-
United States
-
United States Food and Drug Administration*
-
Uridine Monophosphate / analogs & derivatives
-
Uridine Monophosphate / therapeutic use
-
gamma-Cyclodextrins / therapeutic use
Substances
-
Antibodies, Monoclonal, Humanized
-
Azepines
-
Biphenyl Compounds
-
CETP protein, human
-
Cholesterol Ester Transfer Proteins
-
Fumarates
-
Glucosides
-
Lactones
-
Pyridines
-
Thiophenes
-
Triazoles
-
gamma-Cyclodextrins
-
suvorexant
-
Canagliflozin
-
Maytansine
-
Sugammadex
-
solanezumab
-
Uridine Monophosphate
-
Dimethyl Fumarate
-
odanacatib
-
Trastuzumab
-
Ado-Trastuzumab Emtansine
-
Sofosbuvir
-
vorapaxar